{
  "meta": {
    "title": "Basics_And_Cholinergic_Drugs",
    "url": "https://brainandscalpel.vercel.app/basics-and-cholinergic-drugs-d78ec082.html",
    "scrapedAt": "2025-11-29T18:33:40.977Z"
  },
  "questions": [
    {
      "id": 3330,
      "choices": [
        {
          "id": 13299,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fesoterodine</span></span></p>"
        },
        {
          "id": 13300,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trospium</span></span></p>"
        },
        {
          "id": 13301,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mirabegron</span></span></p>"
        },
        {
          "id": 13302,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxybutynin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is the new &beta;3 agonist approved for overactive bladder? </span></span></span></p>",
      "unique_key": "Q6496142",
      "question_audio": null,
      "question_video": null,
      "map_id": 35867,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Mirabegron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mirabegron</strong> is a<strong> &beta;3-adrenoceptor agonist </strong>which is a<strong> newer class of drug</strong> used to <strong>treat overactive bladder.</strong> It works by <strong>relaxing the</strong> <strong>smooth muscle of the bladder</strong>, thereby<strong> increasing bladder capacity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fesoterodine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, it is an<strong> antimuscarinic agent </strong>used for <strong>overactive bladder</strong> but <strong>not a &beta;3 agonist. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Trospium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, also an <strong>antimuscarinic</strong>,<strong> not a &beta;3 agonist</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Oxybutynin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>- Incorrect,</strong> this is an<strong> older antimuscarinic drug </strong>used for <strong>overactive bladder</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mirabegron </strong>is the <strong>first &beta;3 agonist</strong> approved for the treatment of <strong>overactive bladder,</strong> offering a <strong>mechanism of action different </strong>from <strong>antimuscarinic agents, </strong>and can be an option for patients who <strong>cannot tolerate </strong>or <strong>do not respond to anticholinergic medications.</strong></span></span></span></p>",
      "correct_choice_id": 13301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3635,
      "choices": [
        {
          "id": 14519,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertensive emergencies</span></span></span></p>"
        },
        {
          "id": 14520,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congestive heart failure</span></span></span></p>"
        },
        {
          "id": 14521,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migraine prophylaxis</span></span></span></p>"
        },
        {
          "id": 14522,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyarrhythmias</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fenoldopam is used in the management of? </span></span></p>",
      "unique_key": "Q1820733",
      "question_audio": null,
      "question_video": null,
      "map_id": 35872,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Hypertensive emergencies </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fenoldopam </strong>is used in the management of <strong>hypertensive emergencies.</strong> It is a <strong>selective dopamine D1 receptor agonist</strong> that induces <strong>vasodilation of peripheral arterie</strong>s, leading to a <strong>rapid decrease in blood press</strong>ure. One of the advantages of <strong>fenoldopam is its ability</strong> to<strong> enhance renal perfusion</strong>, which is beneficial in<strong> hypertensive emergencies</strong> where<strong> kidney function </strong>may be <strong>compromised.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Congestive heart failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fenoldopam </strong>is <strong>not </strong>typically used in the management of<strong> congestive heart failure (CHF). </strong>Drugs commonly used in <strong>CHF include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists</strong>, which work by different mechanisms to <strong>reduce the workload on the heart </strong>and <strong>improve cardiac output</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Migraine prophylaxis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Fenoldopam </strong>is <strong>not </strong>used for <strong>migraine prophylaxis</strong>. Medications for migraine prevention include <strong>beta-blockers (such as propranolol), calcium channel blockers, antidepressants, and antiepileptic drugs</strong>, which have different mechanisms of action aimed at <strong>reducing the frequency and severity of migraine attacks</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tachyarrhythmias:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fenoldopam </strong>is<strong> not </strong>indicated for the treatment of <strong>tachyarrhythmias. Drugs used </strong>to manage tachyarrhythmias include <strong>beta-blockers, calcium channel blockers, antiarrhythmic agents, and sometimes digoxin</strong>, depending on the<strong> type and cause of the arrhythmia. </strong>These medications work by<strong> modulating cardiac electrical activity </strong>to <strong>normalize heart rhythm</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>specific indications for fenoldopam, </strong>particularly its role in <strong>managing hypertensive emergencies </strong>due to <strong>its vasodilatory effects </strong>and positive impact on <strong>renal perfusion</strong>. Additionally, recognizing that <strong>fenoldopam is not </strong>indicated for<strong> congestive heart failure, migraine prophylaxis, or tachyarrhythmias </strong>underscores the importance of selecting appropriate medications based on the clinical condition being treated.</span></span></p>",
      "correct_choice_id": 14519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3303,
      "choices": [
        {
          "id": 13191,
          "text": "<p><span style=\"font-size:12pt;\">Angle closure glaucoma</span></p>"
        },
        {
          "id": 13192,
          "text": "<p><span style=\"font-size:12pt;\">Asthma</span></p>"
        },
        {
          "id": 13193,
          "text": "<p><span style=\"font-size:12pt;\">Peptic ulcer</span></p>"
        },
        {
          "id": 13194,
          "text": "<p><span style=\"font-size:12pt;\">Urinary incontinence</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">All of the following are indications of antimuscarinic&nbsp;</span><span style=\"font-size:12.0pt;\">drugs except</span><span style=\"color:black;font-size:12.0pt;\">?</span></p>",
      "unique_key": "Q5284000",
      "question_audio": null,
      "question_video": null,
      "map_id": 35878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Angle closure glaucoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Antimuscarinic drugs</strong> are typically used for their <strong>inhibitory action </strong>on the <strong>parasympathetic nervous system</strong>. They can <strong>relax smooth</strong> <strong>muscle</strong>,<strong> reduce body secretions</strong>, and <strong>decrease gastrointestinal motility, </strong>among other effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Angle closure glaucoma </strong>is a<strong> contraindication </strong>for<strong> antimuscarinic drugs </strong>because these medications can further<strong> narrow or close </strong>the already compromised <strong>drainage angles of the eye, </strong>worsening the condition.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Asthma:</strong>&nbsp;<strong>Antimuscarinics </strong>are <strong>used </strong>to relieve<strong> bronchospasm </strong>by <strong>inhibiting constrictive parasympathetic </strong>influences on the <strong>bronchial smooth muscle.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Peptic ulcer:</strong>&nbsp; These drugs <strong>reduce gastric acid secretion </strong>and are used to <strong>treat peptic ulcers.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Urinary incontinence:</strong>&nbsp; <strong>Antimuscarinics</strong> can <strong>relax the bladder, </strong>reducing the <strong>urgency and frequency of urination </strong>in overactive bladder<strong>.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the treatment of various conditions where <strong>parasympathetic inhibition </strong>is <strong>beneficial, antimuscarinic drugs </strong>are indicated; however, they are<strong> contraindicated in angle-closure glaucoma </strong>due to the risk of <strong>exacerbating the condition</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121431.jpg\" alt=\"\" width=\"1000\" height=\"502\"></span></p>",
      "correct_choice_id": 13191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3308,
      "choices": [
        {
          "id": 13211,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in heart rate</span></span></p>"
        },
        {
          "id": 13212,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in heart rate</span></span></p>"
        },
        {
          "id": 13213,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in mean arterial pressure</span></span></p>"
        },
        {
          "id": 13214,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased renal perfusion and reduced urine output</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?</span></span></p>",
      "unique_key": "Q5168986",
      "question_audio": null,
      "question_video": null,
      "map_id": 35881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Increase in mean arterial pressure</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the treatment of<strong> septic shock</strong>, the primary therapeutic goal is to <strong>stabilize hemodynamics </strong>and <strong>improve tissue perfusion</strong>. <strong>Nor-epinephrine (norepinephrine) </strong>is a<strong> potent vasopressor </strong>that <strong>increases both systolic and diastolic blood pressure</strong>. It is commonly used to<strong> counteract the vasodilatory effects of septic shock </strong>and help maintain <strong>adequate organ perfusion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increase in heart rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Not the best indicator </strong>for the efficacy of<strong> nor-epinephrine in septic shock</strong>, as the drug may actually lead to a <strong>reflex bradycardia due to increased blood pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decrease in heart rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - While <strong>nor-epinephrine </strong>can cause a<strong> reflex decrease in heart rate </strong>due to <strong>increased blood pressure, </strong>it&#39;s<strong> not the primary indicator </strong>of therapeutic response in septic shock. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Decreased renal perfusion and reduced urine output</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - These are<strong> potential adverse effects of nor-epinephrine </strong>due to its <strong>vasoconstrictive action</strong>, <strong>not </strong>indicators of a <strong>positive therapeutic response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effectiveness of <strong>nor-epinephrine </strong>in the management of<strong> septic shock </strong>is best<strong> monitored </strong>by an <strong>increase in mean arterial pressure</strong>, aiming to <strong>maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg </strong>to ensure <strong>adequate organ perfusion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harrison 19<sup>th</sup>/1761</span></strong></span></span></p>",
      "correct_choice_id": 13213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3284,
      "choices": [
        {
          "id": 13115,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed angle glaucoma</span></span></span></p>"
        },
        {
          "id": 13116,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia</span></span></span></p>"
        },
        {
          "id": 13117,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cobra bite</span></span></span></p>"
        },
        {
          "id": 13118,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinomimetic drugs can be used for the treatment of all the following conditions except ?</span></span></span></p>",
      "unique_key": "Q6571315",
      "question_audio": null,
      "question_video": null,
      "map_id": 35874,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bradycardia&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs</strong>, which <strong>mimic the action of acetylcholine</strong>, will actually cause<strong> bradycardia </strong>as an <strong>adverse effect </strong>due to their stimulation of <strong>muscarinic receptors in the heart</strong>. Therefore, they are<strong> not used to treat bradycardia</strong>, where the goal is to<strong> increase heart rate</strong>, not decrease it further.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Correct Usage - Closed angle glaucoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is treated with drugs like <strong>Physostigmine and Pilocarpine to increase aqueous humor outflow</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Correct Usage - For a cobra bite:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Neostigmine plus atropine </strong>is used to <strong>counteract the neuromuscular blockade </strong>caused by the <strong>venom</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Correct Usage - In Myasthenia gravis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> drugs such as<strong> Neostigmine </strong>are used to enhance<strong> neuromuscular transmission </strong>by preventing the <strong>breakdown of acetylcholine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Uses of Cholinergic Drugs:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alzheimer&rsquo;s disease </strong>treatment with<strong> Donepezil, Rivastigmine, and Galantamine </strong>to <strong>increase acetylcholine </strong>in the brain.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of <strong>xerostomia </strong>with drugs like <strong>Cevimeline </strong>to stimulate <strong>salivary gland secretion</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Postoperative urinary retention </strong>and <strong>paralytic ileus </strong>managed with drugs like <strong>Bethanechol and Neostigmine </strong>to stimulate the<strong> bladder detrusor muscle and GI motility</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Antidote for anticholinergic poisoning </strong>with<strong> Physostigmine </strong>to counteract <strong>muscarinic receptor blockade.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs </strong>are <strong>not used </strong>for the treatment of<strong> bradycardia </strong>due to their potential to cause a<strong> decrease in heart rate</strong>. They are, however, useful in treating various other conditions where <strong>increased cholinergic action </strong>is beneficial, such as<strong> closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimer&rsquo;s disease.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120058.jpg\" style=\"height:425px; width:1000px\" /></span></span></p>",
      "correct_choice_id": 13116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3306,
      "choices": [
        {
          "id": 13203,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</span></span></p>"
        },
        {
          "id": 13204,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 1 ml of 1:10000 by intravenous route</span></span></p>"
        },
        {
          "id": 13205,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine 3 mg intravenously</span></span></p>"
        },
        {
          "id": 13206,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine 12 mg intravenously</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of choice for anaphylactic shock is</span></span></p>",
      "unique_key": "Q8792050",
      "question_audio": null,
      "question_video": null,
      "map_id": 35880,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline</strong> is the treatment of choice for <strong>anaphylactic shock</strong> due to its <strong>rapid onset of action </strong>and its effects on<strong> both alpha and beta-adrenergic receptors</strong>. It reverses the symptoms of <strong>anaphylaxis by causing peripheral vasoconstriction, bronchodilation, increasing cardiac output</strong>, and<strong> preventing </strong>further release of <strong>mediators </strong>from <strong>mast cells and basophils</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Adrenaline 1 ml of 1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:10000 by intravenous route:</strong>&nbsp;This is<strong> less </strong>preferred initially due to the <strong>risk of adverse effects </strong>with <strong>intravenous administration</strong> unless <strong>absolutely necessary and under close monitoring. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Atropine 3 mg intravenously:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong> Not used in anaphylaxis</strong>, as it does not address the pathophysiological changes involved in anaphylactic shock. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Adenosine 12 mg intravenously:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Not indicated for anaphylaxis </strong>as it&#39;s primarily<strong> used for </strong>certain types of <strong>supraventricular tachycardias.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For<strong> anaphylactic shock</strong>, <strong>adrenaline </strong>is administered <strong>intramuscularly in a 1:1000 concentration as the first-line treatment</strong>. This route is preferred over <strong>subcutaneous or intravenous administration </strong>due to its<strong> effectiveness and safety profile</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harrison 19<sup>th</sup>/2117</span></span></strong></p>",
      "correct_choice_id": 13203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3346,
      "choices": [
        {
          "id": 13363,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></span></p>"
        },
        {
          "id": 13364,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betaxolol</span></span></p>"
        },
        {
          "id": 13365,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxprenolol</span></span></p>"
        },
        {
          "id": 13366,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Labetalol</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are non-selective &beta;-blockers except:</span></span></span></p>",
      "unique_key": "Q1609447",
      "question_audio": null,
      "question_video": null,
      "map_id": 35870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Betaxolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given options, <strong>Betaxolol</strong> is the <strong>beta-blocker</strong> that is <strong>cardioselective</strong>, meaning it <strong>primarily blocks</strong> <strong>beta-1 adrenergic</strong> <strong>receptors</strong> that are<strong> predominantly</strong> found in the <strong>heart</strong>. This selectivity can <strong>reduce </strong>the risk of <strong>bronchoconstriction</strong> and other side effects <strong>related to beta-2 receptor blockade.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardioselective beta-blockers,</strong> sometimes called <strong>beta-1 selective blockers</strong>, are preferred for patients with <strong>asthma or chronic</strong> <strong>obstructive pulmonary disease (COPD) </strong>as they are<strong> less likely </strong>to cause <strong>constriction of the airways</strong>, which is mediated through <strong>beta-2</strong> <strong>receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carvedilol:</strong> A <strong>non-selective beta-blocker</strong> that also has <strong>alpha-blocking activity, </strong>used for the treatment of <strong>high blood</strong> p<strong>ressure and heart failure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxprenolol:</strong> A <strong>non-selective beta-blocker </strong>with <strong>intrinsic sympathomimetic activity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Labetalol:</strong> A <strong>non-selective beta-blocker </strong>that also <strong>blocks alpha-1 receptors </strong>and is commonly used in<strong> pregnancy-induced</strong> <strong>hypertension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Betaxolol </strong>is a <strong>cardioselective beta-blocker</strong> that selectively <strong>blocks beta-1 adrenergic receptors in the heart</strong>, while<strong> Carvedilol,</strong> <strong>Oxprenolol, and Labetalol</strong> are <strong>non-selective beta-blockers </strong>affecting <strong>both</strong> <strong>beta-1 and beta-2 adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardio-selective beta blockers:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/33.jpg\" style=\"height:325px; width:300px\" /></span></strong></span></span></p>",
      "correct_choice_id": 13364,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3290,
      "choices": [
        {
          "id": 13139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tremors</span></span></span></p>"
        },
        {
          "id": 13140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></p>"
        },
        {
          "id": 13141,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></p>"
        },
        {
          "id": 13142,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchodilation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except?</span></span></span></p>",
      "unique_key": "Q9268135",
      "question_audio": null,
      "question_video": null,
      "map_id": 35876,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hypoglycemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;&beta;2 agonists</strong>, like <strong>formoterol</strong>, used as <strong>inhaled bronchodilators </strong>for the management of<strong> bronchial asthma</strong>, can cause a variety of<strong> side effects. Tremors</strong> are a common dose-related side effect due to the stimulation of<strong> &beta;2 receptors in skeletal muscle. Hypokalemia </strong>can occur with the use of<strong> &beta;2 agonists </strong>as they <strong>promote </strong>the <strong>uptake of potassium into cells</strong>, <strong>lowering the potassium concentration</strong> in the <strong>bloodstream</strong>.<strong> Bronchodilation </strong>is the intended therapeutic effect of<strong> &beta;2 agonists</strong>, resulting from the <strong>relaxation of bronchial smooth muscle</strong>. However,<strong> &beta;2 agonists do not </strong>typically cause <strong>hypoglycemia; </strong>in fact, they may <strong>increase blood glucose </strong>levels by<strong> stimulating glycogenolysis and gluconeogenesis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tremors </strong>- A known <strong>side effect </strong>due to the stimulation of<strong> &beta;2 receptors by &beta;2 agonists. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypokalemia </strong>- Can occur as <strong>&beta;2 agonists </strong>increase<strong> intracellular potassium uptake</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Bronchodilation </strong>- The primary therapeutic action of<strong> formoterol in bronchial asthma</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Formoterol, a &beta;2 agonist, does not </strong>cause <strong>hypoglycemia</strong>. Instead, it can cause side effects such as<strong> tremors, hypokalemia </strong>due to <strong>increased potassium uptake into cells</strong>, and the desired effect of <strong>bronchodilation </strong>for the management of<strong> asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "correct_choice_id": 13140,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3276,
      "choices": [
        {
          "id": 13083,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 stimulation by epinephrine following beta 1-stimulation </span></span></span></p>"
        },
        {
          "id": 13084,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of beta-1 receptors following blocking of beta 2 receptors </span></span></span></p>"
        },
        {
          "id": 13085,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of beta-2 receptors following blocking of alpha receptors</span></span></span></p>"
        },
        {
          "id": 13086,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 stimulation by norepinephrine following beta-1 blockade </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an animal model, the phenomenon of vasomotor reversal of Dale can be demonstrated by?</span></span></p>",
      "unique_key": "Q8481934",
      "question_audio": null,
      "question_video": null,
      "map_id": 35873,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stimulation of beta-2 receptors following blocking of alpha receptors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>phenomenon of vasomotor reversal of Dale</strong> describes a situation where the usual <strong>vasoconstrictive effect of epinephrine</strong> <strong>(adrenaline) </strong>is <strong>reversed to vasodilation.</strong> This can occur if the<strong> alpha-adrenergic receptors</strong>, which typically mediate <strong>vasoconstriction, are blocked. </strong>The remaining action is then through the<strong> beta-adrenergic receptors</strong>, which can cause <strong>vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture2.jpg\" style=\"height:151px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A. Beta-2 stimulation by epinephrine following beta 1-stimulation:</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option <strong>does not </strong>describe <strong>vasomotor reversal of Dale</strong>. <strong>Beta-1 stimulation </strong>typically affects <strong>heart rate and contractility</strong>, not vasomotor responses.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options B. Stimulation of beta-1 receptors following blocking of beta 2 receptors:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This also <strong>does not </strong>lead to <strong>vasomotor reversal of Dale</strong>. <strong>Blocking beta-2 receptors </strong>would typically <strong>enhance</strong> the <strong>alpha receptor-mediated vasoconstrictive </strong>effect of <strong>catecholamines, </strong>not reverse it.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C. Stimulation of beta-2 receptors following blocking of alpha receptors:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the <strong>correct option </strong>for demonstrating <strong>vasomotor reversal of Dale. </strong>When <strong>alpha receptors are blocked, </strong>the administration of a <strong>catecholamine </strong>will primarily <strong>stimulate the</strong> <strong>beta-2 adrenergic receptors</strong>, leading to <strong>vasodilation,</strong> which is the <strong>opposite</strong> of the usual<strong> vasoconstrictive effect of catecholamines </strong>on <strong>blood vessels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options D. Beta-2 stimulation by norepinephrine following beta-1 blockade:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Norepinephrine (noradrenaline) </strong>has a much <strong>weaker effect on beta-2 receptors </strong>compared to <strong>alpha receptors</strong>, so <strong>blocking beta-1 receptors would not </strong>typically result in a <strong>vasomotor reversal. Norepinephrine </strong>is more known for its <strong>strong alpha receptor affinity</strong>, leading to <strong>vasoconstriction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> vasomotor reversal of Dale,</strong> characterized by a <strong>switch from vasoconstriction to vasodilation,</strong> is demonstrated by the<strong> stimulation</strong> of <strong>beta-2 receptors</strong> after <strong>alpha receptors have been blocked, </strong>showcasing the <strong>unique and sometimes counterintuitive effect</strong>s that can result from the <strong>complex interplay of the autonomic nervous system&#39;s receptors.</strong></span></span></span></p>",
      "correct_choice_id": 13085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3286,
      "choices": [
        {
          "id": 13123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastric secretion</span></span></span></p>"
        },
        {
          "id": 13124,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuromuscular junction</span></span></span></p>"
        },
        {
          "id": 13125,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sweat glands</span></span></span></p>"
        },
        {
          "id": 13126,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ureteral tone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses have significantly different effects on which of the following? </span></span></span></p>",
      "unique_key": "Q9125545",
      "question_audio": null,
      "question_video": null,
      "map_id": 35875,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Neuromuscular junction </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bethanechol </strong>is a <strong>cholinomimetic agent </strong>that selectively stimulates <strong>muscarinic receptors without </strong>any effect on<strong> nicotinic receptors </strong>such as those found at the<strong> neuromuscular junction (NMJ). Physostigmine, an acetylcholinesterase inhibitor</strong>, <strong>increases levels </strong>of <strong>acetylcholine </strong>at <strong>both muscarinic and nicotinic receptors. </strong>The neuromuscular junction, which <strong>contains nicotinic receptors</strong>, will be affected by <strong>physostigmine </strong>due to <strong>increased acetylcholine</strong> leading to stimulation of these<strong> receptors.</strong> However, <em>bethanechol </em>would <strong>not affect the NMJ </strong>as it <strong>lacks action on nicotinic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Gastric secretion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is mediated by<strong> muscarinic receptors</strong>; thus,<strong> both drugs</strong> would <strong>enhance secretion. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sweat glands:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are also regulated by<strong> muscarinic receptors, </strong>so <strong>both physostigmine and bethanechol </strong>would stimulate <strong>sweating. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ureteral tone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is under the <strong>control of muscarinic receptors, </strong>hence <strong>both drugs </strong>could <strong>increase ureteral tone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Physostigmine</strong> can affect <strong>both muscarinic and nicotinic receptors,</strong> making it effective <strong>at the neuromuscular junction,</strong> while <strong>bethanechol&#39;s</strong> action is limited to <strong>muscarinic receptors</strong> and <strong>does not </strong>influence <strong>neuromuscular transmission.</strong></span></span></span></p>",
      "correct_choice_id": 13124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3298,
      "choices": [
        {
          "id": 13171,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
        },
        {
          "id": 13172,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha agonist</span></span></span></p>"
        },
        {
          "id": 13173,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span></span></span></p>"
        },
        {
          "id": 13174,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blocker</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male with insulin dependent diabetes having macular edema develops glaucoma. Which of the following anti-glaucoma drugs should be avoided in this patient?&nbsp; </span></span></span></p>",
      "unique_key": "Q7451294",
      "question_audio": null,
      "question_video": null,
      "map_id": 35877,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues,</strong> such as <strong>latanoprost, bimatoprost, and travoprost, </strong>are commonly used to <strong>lower intraocular pressure in</strong> patients with<strong> glaucoma by increasing the outflow of aqueous humor.</strong> However, they have been <strong>associated with</strong> a potential<strong> risk of</strong> <strong>exacerbating macular edema,</strong> particularly in patients with<strong> pre-existing condition</strong>s that predispose them to <strong>retinal edema,</strong> such as <strong>diabetic retinopathy</strong>. In a patient with <strong>insulin-dependent diabetes</strong> and<strong> macular edema,</strong> the use of prostaglandin analogues could potentially worsen the macular edema, thus they should be used with caution or avoided.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Alpha agonist:</strong> Alpha agonists, such as <strong>brimonidine, </strong>work by <strong>decreasing aqueous humor production </strong>and <strong>increasing uveoscleral outflow</strong>. They are <strong>not </strong>specifically<strong> contraindicated in patients </strong>with <strong>diabetic macular edema </strong>and can be used in the management of<strong> glaucoma </strong>in such patients.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Pilocarpine:</strong> Pilocarpine is a <strong>cholinergic agonist </strong>that <strong>works by constricting the pupil </strong>and <strong>pulling the iris away from the trabecular meshwork</strong>, thus <strong>improving the outflow of aqueous humor</strong>. While it is <strong>less commonly</strong> used due to its<strong> side effects</strong> and the <strong>availability of more effective treatments</strong>, <strong>pilocarpine</strong> is <strong>not</strong> specifically <strong>contraindicated in patients with diabetic macular edema.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Beta blocker:</strong> Beta blockers, such as <strong>timolol</strong>, work by <strong>decreasing the production of aqueous humor.</strong> They are a common choice for the <strong>treatment of glaucoma</strong> and do not directly affect the<strong> retina or exacerbate macular edema</strong>. Therefore, <strong>beta blockers </strong>can be considered for use in patients with<strong> both glaucoma and diabetic macular edema</strong>, provided there are <strong>no other contraindications (e.g., respiratory conditions).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with <strong>macular edema, prostaglandin analogues</strong> may exacerbate <strong>macular edema</strong> and should be used <strong>cautiously or avoided</strong>. It is important to consider the <strong>systemic and ocular side effects of glaucoma medications</strong>, especially in patients with <strong>pre-existing </strong>conditions such as<strong> diabetic retinopathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/2000_vzyqPnB.jpg\" style=\"height:1116px; width:1000px\" /></p>",
      "correct_choice_id": 13171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3304,
      "choices": [
        {
          "id": 13195,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
        },
        {
          "id": 13196,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
        },
        {
          "id": 13197,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Noradrenaline</span></span></span></p>"
        },
        {
          "id": 13198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous infusion of which of the following drugs may result in decrease in heart rate?</span></span></span></p>",
      "unique_key": "Q4810860",
      "question_audio": null,
      "question_video": null,
      "map_id": 35879,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Noradrenaline </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline (norepinephrine)</strong> is a <strong>sympathomimetic amine </strong>that predominantly acts on <strong>alpha-adrenergic receptors</strong>, causing <strong>vasoconstriction and increasing blood pressure</strong>. Although it also has <strong>beta-1 adrenergic activity </strong>that can<strong> increase heart rate</strong>, the <strong>dominant effect </strong>of <strong>noradrenaline-induced vasoconstriction </strong>leads to a <strong>reflex bradycardia</strong>. This reflex is mediated by the <strong>baroreceptor</strong> reflex; as <strong>blood pressure </strong>rises due to <strong>vasoconstriction, </strong>the <strong>baroreceptors</strong> in the <strong>carotid sinus and aortic arch sense</strong> this <strong>increase and stimulate the vagus nerve </strong>to <strong>slow the heart rate </strong>in an attempt to <strong>balance the cardiovascular effects </strong>and<strong> maintain homeostasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline:&nbsp;</strong>Adrenaline (epinephrine) acts on <strong>both alpha and beta-adrenergic receptors. </strong>Its action on <strong>beta-1 receptors </strong>in the heart typically <strong>increases heart rate and cardiac output. </strong>Thus, intravenous <strong>infusion of adrenaline</strong> is more likely to <strong>increase rather</strong> than <strong>decrease heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Isoprenaline:&nbsp;</strong>Isoprenaline (isoproterenol) is a <strong>synthetic sympathomimetic amine </strong>that acts predominantly on <strong>beta-adrenergic receptors</strong>, including<strong> beta-1 receptors in the heart</strong>, leading to an <strong>increase in heart rate and cardiac output</strong>. It <strong>does not </strong>cause a<strong> decrease in heart rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dobutamine:</strong> Dobutamine is a <strong>beta-1 adrenergic agonist </strong>with <strong>strong inotropic effects </strong>but relatively <strong>mild chronotropic </strong>effects compared to <strong>isoprenaline</strong>. It primarily <strong>increases the strength of heart muscle contraction </strong>and slightly <strong>increases heart rate </strong>but is primarily used for <strong>its inotropic effect in heart failure</strong>. It is <strong>less likely </strong>to cause a<strong> decrease in heart rate </strong>compared to <strong>noradrenaline&#39;s reflex bradycardia effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the <strong>cardiovascular effects of different sympathomimetic amines</strong>, particularly their impact on<strong> heart rate</strong>. While <strong>adrenaline, isoprenaline, and dobutamine </strong>generally <strong>increase heart rate </strong>due to their<strong> beta-1 adrenergic receptor activity</strong>, <strong>noradrenaline </strong>can lead to a reflex <strong>decrease in heart rate (bradycardia) </strong>through <strong>increased blood pressure </strong>and <strong>subsequent activation of the baroreceptor reflex</strong>.</span></span></span></p>",
      "correct_choice_id": 13197,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3317,
      "choices": [
        {
          "id": 13247,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
        },
        {
          "id": 13248,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
        },
        {
          "id": 13249,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
        },
        {
          "id": 13250,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs can cross blood brain barrier? </span></span></span></p>",
      "unique_key": "Q1844164",
      "question_audio": null,
      "question_video": null,
      "map_id": 35882,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) i.e. Physostigmine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Physostigmine </strong>is known for its ability to be <strong>rapidly absorbed from the gastrointestinal tract </strong>and through <strong>parenteral administration</strong> <strong>routes.</strong> Its chemical structure allows it to <strong>penetrate the cornea and cross the blood-brain barrier (BBB)</strong>, thus exerting effects on the <strong>central nervous system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glycopyrrolate:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect,</strong> as it is a <strong>potent antimuscarinic agent</strong> with <strong>rapid action </strong>but <strong>lacks central effects </strong>due to its <strong>inability to cross the BBB. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Neostigmine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect</strong> because it is a<strong> quaternary ammonium compound</strong>, which results in <strong>poor oral absorption</strong>, <strong>limited</strong> <strong>corneal penetration</strong>, and an<strong> inability to cross the BBB.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to remember that <strong>physostigmine can cross the blood-brain barrier, </strong>distinguishing it from other <strong>anticholinesterases</strong> like<strong> neostigmine</strong> and <strong>antimuscarinics like glycopyrrolate, which cannot.</strong></span></span></span></p>",
      "correct_choice_id": 13249,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3318,
      "choices": [
        {
          "id": 13251,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle tremors</span></span></span></p>"
        },
        {
          "id": 13252,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></p>"
        },
        {
          "id": 13253,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemic attacks</span></span></span></p>"
        },
        {
          "id": 13254,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sedation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common adverse effect of short acting beta 2 agonists used in bronchial asthma is?</span></span></span></p>",
      "unique_key": "Q5453820",
      "question_audio": null,
      "question_video": null,
      "map_id": 35883,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Muscle tremors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle tremors </strong>are the most common adverse effect associated with <strong>beta-2 agonists</strong> due to the <strong>stimulation of beta-2 receptors</strong> in <strong>skeletal muscles</strong>. This effect is <strong>more pronounced </strong>when these medications are used at <strong>higher doses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypokalemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Incorrect, </strong>while <strong>beta-2 agonists </strong>can cause <strong>hypokalemia</strong> due to the <strong>intracellular shift of potassium, </strong>it is <strong>not</strong> the most common <strong>adverse effect. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypoglycemic attacks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Incorrect, hypoglycemia</strong> is <strong>not</strong> a typical adverse effect of <strong>beta-2 agonists. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sedation:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Incorrect,</strong> <strong>beta-2 agonists</strong> typically <strong>do no</strong>t cause <strong>sedation as an adverse effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common adverse effect of <strong>short-acting beta-2 agonists </strong>in the treatment of <strong>bronchial asthma is muscle tremors, </strong>which occur due to <strong>direct stimulation of the beta-2 receptors </strong>in<strong> skeletal muscles.</strong></span></span></p>",
      "correct_choice_id": 13251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3321,
      "choices": [
        {
          "id": 13263,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fenoldopam </span></span></span></p>"
        },
        {
          "id": 13264,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
        },
        {
          "id": 13265,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine </span></span></span></p>"
        },
        {
          "id": 13266,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug possess agonistic property on alpha 1, alpha 2, beta 1 and beta 2 adrenergic receptors?</span></span></p>",
      "unique_key": "Q5085692",
      "question_audio": null,
      "question_video": null,
      "map_id": 35884,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Epinephrine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine, </strong>also known as <strong>adrenaline,</strong> is a <strong>non-selective adrenergic agonist</strong> that stimulates <strong>both alpha- and beta-adrenergic</strong> <strong>receptors</strong>. It possesses <strong>agonistic properties on alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-1 adrenergic receptor</strong> activation causes<strong> vasoconstriction</strong>, leading to <strong>increased blood pressure.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-2 adrenergic receptor</strong> activation results in <strong>peripheral vasodilation</strong> and <strong>reduced peripheral resistance.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-1 adrenergic receptor </strong>activation<strong> increases heart rate, cardiac contractility, and conduction velocity </strong>in the heart.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 adrenergic receptor</strong> activation leads to<strong> bronchodilation and vasodilation </strong>in <strong>skeletal muscle </strong>and other <strong>vascular beds.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine </strong>is commonly used in<strong> emergency medicine </strong>for <strong>its effects </strong>on the<strong> cardiovascular system, bronchodilation</strong>, and <strong>its ability to counteract severe allergic reactions (anaphylaxis).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fenoldopam:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fenoldopam is a <strong>selective dopamine-1 receptor agonist </strong>used for the management of<strong> hypertension</strong>. It does <strong>not </strong>possess <strong>agonistic properties on alpha or beta adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dopamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Dopamine primarily<strong> acts on dopamine receptors,</strong> but at<strong> higher doses,</strong> it can also stimulate <strong>alpha and beta</strong> <strong>adrenergic receptors</strong>. However, dopamine is <strong>not as potent</strong> or <strong>selective as epinephrine </strong>in its actions on <strong>adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Phenylephrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Phenylephrine is a <strong>selective alpha-1 adrenergic receptor agonist</strong> used primarily as a <strong>decongestant</strong> and to <strong>raise blood pressure </strong>in cases of<strong> hypotension</strong>. It <strong>does not</strong> possess <strong>agonistic properties</strong> on<strong> beta adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine,</strong> as a<strong> non-selective adrenergic agonist</strong>, stimulates <strong>alpha-1, alpha-2, beta-1, and beta-2</strong> adrenergic receptors, leading to a wide range of<strong> cardiovascular and bronchodilatory effects.</strong> This knowledge guides its use in<strong> emergency situation</strong>s such as <strong>anaphylaxis, cardiac arrest, and severe asthma exacerbations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122030.jpg\" style=\"height:522px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 13265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3326,
      "choices": [
        {
          "id": 13283,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia</span></span></span></p>"
        },
        {
          "id": 13284,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glaucoma</span></span></span></p>"
        },
        {
          "id": 13285,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis</span></span></span></p>"
        },
        {
          "id": 13286,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-surgical atony or ileus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinomimetic drugs are not used in which of the following conditions?</span></span></span></p>",
      "unique_key": "Q2784313",
      "question_audio": null,
      "question_video": null,
      "map_id": 35885,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bradycardia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs,</strong> which <strong>mimic the action of acetylcholine</strong>, are <strong>not</strong> used in the management of <strong>bradycardia. </strong>In fact, they could <strong>exacerbate bradycardia </strong>by <strong>stimulating muscarinic receptors in the heart, </strong>which can <strong>decrease heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glaucoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong> because <strong>cholinomimetics like Pilocarpine</strong> are used to <strong>increase trabecular outflow</strong> and <strong>decrease</strong> <strong>intraocular pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Myasthenia gravis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as <strong>cholinomimetics</strong> improve <strong>muscle strength </strong>by <strong>enhancing neuromuscular transmission. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Post-surgical atony or ileus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>since <strong>cholinomimetics </strong>are used to <strong>stimulate GI motility </strong>and <strong>resolve atony or ileus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs</strong> should <strong>not </strong>be used to <strong>treat bradycardia</strong> as they can<strong> slow down the heart rate furthe</strong>r, being <strong>agonists at</strong> <strong>muscarinic receptors</strong> in the heart.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122644.jpg\" style=\"height:424px; width:1000px\" /></span></span></p>",
      "correct_choice_id": 13283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3334,
      "choices": [
        {
          "id": 13315,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></span></p>"
        },
        {
          "id": 13316,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></span></p>"
        },
        {
          "id": 13317,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acebutolol</span></span></span></p>"
        },
        {
          "id": 13318,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta adrenergic blocker having cardioselectivity, intrinsic sympathomimetic activity and membrane stabilizing property is? </span></span></span></p>",
      "unique_key": "Q8118589",
      "question_audio": null,
      "question_video": null,
      "map_id": 35868,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acebutolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acebutolol </strong>is the<strong> beta-blocker </strong>that possesses <strong>cardioselectivity, intrinsic sympathomimetic activity (ISA),</strong> and <strong>membrane-stabilizing</strong> <strong>activity (MSA).</strong> This makes it uniquely suited for patients who may <strong>benefit from </strong>these <strong>specific pharmacological properties</strong>. <strong>Acebutolol&#39;s cardioselectivity </strong>allows it to preferentially target <strong>beta-1 adrenergic receptors in the heart,</strong> which is desirable in patients with <strong>respiratory conditions like asthma, </strong>as it <strong>minimizes </strong>the risk of <strong>bronchoconstriction</strong> associated with<strong> beta-2 receptor blockade</strong>. Its <strong>intrinsic sympathomimetic activity </strong>offers mild <strong>agonistic effect</strong> at the <strong>same receptors it blocks,</strong> which can be<strong> beneficial in patients</strong> who need a<strong> beta-blocker</strong> but are at <strong>risk of bradycardia or have decreased cardiac output.</strong> The <strong>membrane-stabilizing activity,</strong> although <strong>not</strong> a primary therapeutic action when given at <strong>therapeutic doses</strong>, can contribute to its <strong>antiarrhythmic effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Carvedilol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a<strong> non-selective beta-blocker </strong>with <strong>alpha-1 adrenergic blocking activity,</strong> making it effective in <strong>reducing blood pressure</strong> through <strong>vasodilation</strong>. It <strong>lacks intrinsic sympathomimetic activity</strong> and <strong>does not </strong>preferentially target <strong>beta-1 receptors</strong>, making it <strong>less ideal for patients</strong> with <strong>respiratory risks. Carvedilol </strong>is often chosen for <strong>its potent</strong> <strong>antihypertensive effects</strong> and <strong>benefits in heart failure</strong> management but <strong>does no</strong>t have the <strong>combined properties</strong> mentioned in the question.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Atenolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Atenolol is a <strong>cardioselective beta-blocker,</strong> targeting <strong>beta-1 adrenergic receptors</strong>, which <strong>reduces its</strong> risk of <strong>bronchoconstriction </strong>in patients with<strong> asthma or chronic obstructive pulmonary disease (COPD).</strong> However, it <strong>lacks</strong> <strong>intrinsic sympathomimetic activity </strong>and<strong> does not</strong> have significant<strong> membrane-stabilizing activity,</strong> limiting its use in certain <strong>clinical scenarios </strong>where these properties are <strong>desired.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Metoprolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Similar to atenolol,</strong> metoprolol is cardioselective but <strong>does not</strong> possess <strong>intrinsic sympathomimetic</strong> <strong>activity</strong> or significant <strong>membrane-stabilizing activity.</strong> It is widely used for its<strong> cardiovascular benefits,</strong> including <strong>hypertension management, heart failure treatment</strong>, and <strong>myocardial infarction</strong> recovery, but it <strong>does not</strong> meet the criteria of having <strong>all three specified properties.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>pharmacological properties </strong>and <strong>clinical implications</strong> of <strong>selecting specific beta-blockers </strong>for <strong>treatment.</strong> Recognizing the u<strong>nique attributes of beta-blockers</strong>, such as <strong>cardioselectivity, intrinsic sympathomimetic activity,</strong> and <strong>membrane-stabilizing activity,</strong> is crucial in <strong>tailoring therapy</strong> to<strong> individual patient needs,</strong> especially considering <strong>potential comorbid</strong> <strong>conditions. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardioselective beta blockers: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/10.jpg\" style=\"height:1023px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers with intrinsic sympathomimetic activity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/12.jpg\" style=\"height:548px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers with membrane stabilizing property&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/20.jpg\" style=\"height:526px; width:1000px\" /></p>",
      "correct_choice_id": 13317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3339,
      "choices": [
        {
          "id": 13335,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If A,B,C are correct</span></span></span></p>"
        },
        {
          "id": 13336,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If A and C are correct</span></span></span></p>"
        },
        {
          "id": 13337,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If B and D are correct</span></span></span></p>"
        },
        {
          "id": 13338,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If all 4 are correct</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are uses of cholinergic drugs owing to their muscarinic actions? </span></span></span></p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sjogren&rsquo;s syndrome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&#39;s disease</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paralytic ileus</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cobra bite</span></span></span></li>\r\n</ol>",
      "unique_key": "Q5673071",
      "question_audio": null,
      "question_video": null,
      "map_id": 35869,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) If A,B,C are correct</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic drugs,</strong> which<strong> mimic</strong> the <strong>action of acetylcholine,</strong> have various<strong> therapeutic uses </strong>due to their <strong>muscarinic actions</strong>. Let&#39;s examine the options:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A) Sjogren&rsquo;s syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic drugs </strong>are used to <strong>stimulate saliva and tear production in patients </strong>with <strong>Sjogren&rsquo;s syndrome, </strong>a condition characterized by <strong>dry mouth and dry eyes </strong>due to <strong>autoimmune destruction </strong>of the <strong>salivary and lacrimal glands. </strong>Their <strong>muscarinic actions</strong> enhance<strong> glandular secretion.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B) Alzheimer&#39;s disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Cholinergic drugs, specifically <strong>cholinesterase inhibitors,</strong> are used in <strong>Alzheimer&#39;s disease</strong> to <strong>increase acetylcholine levels</strong> in the <strong>brain </strong>and<strong> improve cognitive function. </strong>This <strong>acetylcholine</strong> works on<strong> muscarinic</strong> <strong>receptors</strong> to <strong>improve memory. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C) Paralytic ileus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinergic drug</strong>s are used to <strong>stimulate gastrointestinal motility</strong> in conditions like<strong> paralytic</strong> <strong>ileus</strong> by acting on <strong>muscarinic receptors in the gut, </strong>thereby <strong>alleviating the condition.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D) Cobra bite:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Treatment for a cobra bite</strong> primarily involves<strong> antivenom and supportive care. Cholinergic drugs</strong> like<strong> neostigmine</strong> is used to <strong>stimulate the Nm receptors </strong>and <strong>reverse </strong>the actions of the <strong>venom on neuromuscular</strong> <strong>junction. </strong>However the <strong>therapeutic</strong> approach <strong>does not </strong>center on <strong>muscarinic actions of cholinergic drugs </strong>in this condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Sjogren&rsquo;s syndrome),</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Option B (Alzheimer&#39;s disease) and Option C (Paralytic ileus)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are correct uses of <strong>cholinergic drugs</strong> due to their<strong> muscarinic actions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Cobra bite)</span></strong><strong> </strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is use of<strong> cholinergic drugs</strong> due to action on <strong>nicotinic receptors </strong>and not muscarinic action.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to understand the <strong>therapeutic applications of cholinergic drugs,</strong> particularly through their<strong> muscarinic</strong> <strong>actions</strong>, in various medical conditions. Recognizing how these drugs work can <strong>help in selecting appropriate treatment </strong>options for conditions like <strong>Sjogren&rsquo;s syndrome, Alzheimer&rsquo;s disease and paralytic ileus,</strong> while also understanding the <strong>limitations and specificity</strong> of their<strong> use </strong>in<strong> other disorders.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/121.jpg\" style=\"height:608px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/222.jpg\" style=\"height:680px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 13335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3347,
      "choices": [
        {
          "id": 13367,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
        },
        {
          "id": 13368,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></p>"
        },
        {
          "id": 13369,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxprenolol</span></span></p>"
        },
        {
          "id": 13370,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following beta blockers can cross blood brain barrier except? </span></span></span></p>",
      "unique_key": "Q4978319",
      "question_audio": null,
      "question_video": null,
      "map_id": 35871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Atenolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipid soluble beta blockers </strong>can <strong>cross blood brain barrier</strong> whereas<strong> water soluble beta blockers cannot.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Water soluble beta blockers</strong> include:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A: A</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">tenolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">N: N</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">adolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">S: S</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">otalol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The <strong>ability </strong>of a <strong>beta-blocker </strong>to <strong>cross the blood-brain barrier</strong> is influenced by <strong>its solubility. Lipid-soluble drugs</strong> can <strong>cross more easily,</strong> while <strong>water-soluble drugs do not</strong>. This <strong>property affects the drug&#39;s central nervous system side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol:</strong> A <strong>lipid-soluble beta-blocker</strong> that <strong>can cross the blood-brain barrier</strong> and may cause<strong> CNS side effects. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxprenolol:</strong> A <strong>lipid-soluble beta-blocker </strong>with <strong>partial lipid solubility </strong>and can have<strong> some penetration into the CNS. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Timolol:</strong> A<strong> beta-blocker </strong>with some <strong>lipid solubility, </strong>which allows it to <strong>cross the blood-brain barrier.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atenolol is a water-soluble beta-blocker </strong>that <strong>does not cross the blood-brain barrie</strong>r, making it a preferable option for patients at <strong>risk</strong> of <strong>CNS side effects </strong>and requiring careful use in<strong> patients with renal impairment</strong> due to its <strong>excretion predominantly </strong>via the <strong>kidneys.</strong></span></span></span></p>",
      "correct_choice_id": 13368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}